Fig 1.
Definition of escalation of treatment.
Table 1.
Baseline characteristics of included participants.
Table 2.
Summary of key outcome data over 16 week period of study.
Fig 2.
Proportion of days in flare by mean POEM scores for AE severity.
Table 3.
Odds of experiencing an AE flare (escalation of treatment) and odds of using anti-inflammatory medication by self-reported bother scores each day.
Table 4.
Odds of escalation of treatment and odds of using topical anti-inflammatory medication by change in bother score compared to the previous day.
Table 5.
Mean increase in AE severity scales per unit increase in number of days when treatment escalated and use of a topical anti-inflammatory.